Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma-Reference-Cited by-同舟云学术

Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma

Published:2011-11-17 Issue:2 Volume:88 Page:159-166
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Hsiao Liang-Tsai,Yang Ching-Fen,Yang Sheng-Hsiang,Gau Jyh-Pyng,Yu Yuan-Bin,Hong Ying-Chung,Liu Chun-Yu,Liu Jin-Hwang,Chen Po-Min,Chiou Tzeon-Jye,Tzeng Cheng-Hwai

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2011.01717.x/fullpdf

Reference34 articles.

1. International staging system for multiple myeloma;Greipp;J Clin Oncol,2005

2. The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function;Dimopoulos;Ann Oncol,2011

3. Renal failure in multiple myeloma. Pathogenesis and prognostic implications;Alexanian;Arch Intern Med,1990

4. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution;Blade;Arch Intern Med,1998

5. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council Trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents;Hematological Oncology;2021-12-12

2. Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients;Journal of Clinical Laboratory Analysis;2020-07-25

3. Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?;Oncotarget;2017-05-23

4. Renal Function and All-Cause Mortality Risk Among Cancer Patients;Medicine;2016-05

5. The Rationale and Evidence Base for the Direct Removal of Serum-Free Light Chains in the Management of Myeloma Kidney;Advances in Chronic Kidney Disease;2012-09